Since the beginning of time, humanity has searched for drugs that can relieve pain without sparking addiction or the other ...

IO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients. Click ...

Peptides are gaining steam as ways to fight aging, build muscle, and burn fat. Here's what doctors want you to know before you take the shots.

Veru Inc. ( NASDAQ: VERU) Q3 2025 Earnings Call August 12, 2025 8:00 AM ET K. Gary Barnette - Chief Scientific Officer Michael J. Purvis - Executive VP, General Counsel & Corporate Strategy and ...

International Myeloma Foundation Chief Medical Office Joseph Mikhael, MD, shares how the M-Power initiative is addressing ...

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...

Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Greetings, and welcome to the INmune Bio Second Quarter 2025 ...

The pharmaceutical giant's journey with Celonis has evolved from operational efficiency to enabling enterprise AI ...

Peptide therapeutics are rapidly emerging as a promising class of interventions for obesity, driven by growing insights into their ability to modulate key ...

Antidepressants don’t work, we often hear these days – except for roughly half of patients, for whom they provide significant ...

And in the clinical trials industry where we operate, it’s even more unpredictable. You can put months of work into a project ...

In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’ ...